In vivo antibacterial activity of disodium -sulfobenzylpenicillin.
D000284:Administration, Oral; D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D001424:Bacterial Infections / Q000188:drug therapy; D002228:Carbenicillin / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000188:drug therapy; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D051379:Mice; D010400:Penicillin G / Q000008:administration & dosage / Q000627:therapeutic use*; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D013296:Streptococcus pneumoniae; D013451:Sulfonic Acids / Q000008:administration & dosage / Q000627:therapeutic use
D013451:Sulfonic Acids; D000667:Ampicillin; D002228:Carbenicillin; D010400:Penicillin G